TrialJAMA cardiology2022

Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial.

G Michael Felker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.